Roger Garceau
Director/Board Member presso ENTERA BIO LTD.
Patrimonio netto: 140 580 $ in data 31/03/2024
Posizioni attive di Roger Garceau
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| ENTERA BIO LTD. | Director/Board Member | 01/03/2016 | - |
| Chief Executive Officer | 10/08/2020 | 04/01/2021 | |
| PROTARA THERAPEUTICS, INC. | Director/Board Member | 01/01/2019 | - |
| Independent Dir/Board Member | 01/01/2019 | - | |
Fluorinov Pharmaceuticals, Inc.
 Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Director/Board Member | 04/05/2015 | - |
Enterome SA
 Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Director/Board Member | 01/12/2016 | - |
| Independent Dir/Board Member | 01/12/2016 | - |
Storia della carriera di Roger Garceau
Precedenti posizioni note di Roger Garceau
| Società | Posizione | Inizio | Fine |
|---|---|---|---|
| NPS PHARMACEUTICALS, INC. | Chief Tech/Sci/R&D Officer | 11/06/2009 | 01/02/2015 |
| Sales & Marketing | 11/12/2008 | 11/06/2009 | |
ArTara Subsidiary, Inc.
 ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Director/Board Member | 01/01/2019 | - |
Formazione di Roger Garceau
| Fairfield University | Undergraduate Degree |
| UMass Chan Medical School | Doctorate Degree |
Statistiche
Distribuzione geografica
| Stati Uniti | 7 |
| Francia | 2 |
| Israele | 2 |
Posizioni
| Director/Board Member | 5 |
| Independent Dir/Board Member | 2 |
| Chief Tech/Sci/R&D Officer | 1 |
Settori
| Health Technology | 7 |
| Consumer Services | 3 |
Posizioni ricoperte
Attive
Inattive
Società quotate in Borsa
Aziende private
Società collegate
| Società quotate in Borsa | 2 |
|---|---|
| ENTERA BIO LTD. | Health Technology |
| PROTARA THERAPEUTICS, INC. | Health Technology |
| Aziende private | 4 |
|---|---|
NPS Pharmaceuticals, Inc.
 NPS Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology NPS Pharmaceuticals, Inc. developed drugs for bone and mineral disorders. It also developed Natpara for the treatment of adult hypoparathyroidism. The company was founded by Hunter Jackson and Thomas N. Parks on October 22, 1986 and is headquartered in Bedminster, NJ. | Health Technology |
Enterome SA
Enterome SA Pharmaceuticals: MajorHealth Technology Enterome SA develops personalized medical-tests and diagnostics. The firm profiles human gut microbiome to improve management of microbiome-related disease. It primarily specializes in research adn development focusing on disease management. The company was founded by Stanislav Dusko Ehrlich in 2012 and is headquartered in Paris, France. | Health Technology |
Fluorinov Pharmaceuticals, Inc.
Fluorinov Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Fluorinov Pharmaceuticals, Inc. manufactures pharmaceutical products. The American company was founded by Abdelmalik Slassi. | Health Technology |
ArTara Subsidiary, Inc.
ArTara Subsidiary, Inc. Pharmaceuticals: MajorHealth Technology ArTara Subsidiary, Inc. engages in the research and development of specialty diseases therapeutics. Its programs focus on the treatment of rare diseases in structural and connective tissues, as well as rare hepatology or gastrointestinal and metabolic disorders. The company was founded by Jesse Shefferman in 2017 and is headquartered in New York, NY. | Health Technology |
- Borsa valori
- Insiders
- Roger Garceau
- Esperienza
